Experimental evaluation of L-dopa penetration in brain
De la Torre, J.C.; Mullan, S.
Transactions of the American Neurological Association 96: 227-229
1971
ISSN/ISBN: 0065-9479 PMID: 5159088 Document Number: 38351
Document emailed within 1 workday
Related Documents
Maĭzelis, M.I. 1971: Penetration of radioactive isotopes into regions of the brain during experimental convulsions Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 71(9): 1355-1358Lovedova, E.L. 1988: Effect of L-DOPA on the function of the brain neuromediator systems Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(7): 19-21
Sosedova, L.M.; Novikov, M.A.; Titov, E.A.; Rukavishnikov, V.S. 2015: Evaluation of biologic effects caused by nano-silver influence on brain tissue of experimental animals Meditsina Truda i Promyshlennaia Ekologiia 4: 26-30
Ng, L.K.; Colburn, R.W.; Kopin, I.J. 1972: Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates Journal of Pharmacology and Experimental Therapeutics 183(2): 316-325
Waisman, M.; Schweppy, I. 1979: Experimental study on healing of bone fractures using L-dopa Clinical Orthopaedics and Related Research 142: 244-248
Evans, B.D.; Vogel, W.H. 1977: Penetration of some O-and/or N-methylated norepinephrine derivatives through the rat blood brain barrier Research Communications in Chemical Pathology and Pharmacology 17(1): 61-76
Extein, I.; Roth, R.H.; Bowers, M.B. 1974: Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa Biological Psychiatry 9(2): 161-170
Silva, C.; Mor, M.; Bordi, F.; Rivara, S.; Caretta, A.; Ballabeni, V.; Barocelli, E.; Plazzi, P.V. 1997: Plasma concentration and brain penetration of the H3-receptor antagonist thioperamide in rats Farmaco 52(6-7): 457-462
Minn, A.; Gayet, J. 1973: Preliminary study using an indirect method, of the penetration of anions into isolated brain mitochondria in the rat Journal de Physiologie 67(3): 352a
Markovska, V.; Georgiev, V.; Ankov, V. 1979: Influence of x-ray irradiation on the effects of apomorphine and L-dopa with respect to the dopamine level in rat brain and corpus striatum Acta Physiologica et Pharmacologica Bulgarica 5(4): 27-34
Masse, R.; Sebastien, P.; Monchaux, G.; Bignon, J. 1980: Experimental demonstration of the penetration of asbestos fibres into the gastrointestinal tract Iarc Scientific Publications 30: 321-328
Bizzarri, B.Mattia.; Tortolini, S.; Rotelli, L.; Botta, G.; Saladino, R. 2015: Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity Current Medicinal Chemistry 22(36): 4138-4165
Bergonzi, P.; Chiurulla, C.; Gambi, D.; Mennuni, G.; Pinto, F. 1975: L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment Acta Neurologica Belgica 75(1): 5-10
Hansson, C.; Rorsman, H.; Rosengren, E. 1981: Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid Acta Dermato-Venereologica 61(2): 147-148
Riley, P.A. 1999: The great DOPA mystery: the source and significance of DOPA in phase i melanogenesis Cellular and Molecular Biology 45(7): 951-960
Guillard, A. 1972: Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor Bruxelles Medical 52(10): 673-680
Routh, J.I.; Bannow, R.E.; Fincham, R.W.; Stoll, J.L. 1971: Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy Clinical Chemistry 17(9): 867-871
Vasil'ev, V.N. 1980: Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients Voprosy Meditsinskoi Khimii 26(6): 782-786
Zabel, M. 1979: Ultrastructure of thyroid C cells following long-term administration of 1-DOPA or alpha-methyl-DOPA Acta Medica Polona 20(1): 53-54
Blair, M.L.; Reid, I.A.; Ganong, W.F. 1977: Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs Journal of Pharmacology and Experimental Therapeutics 202(1): 209-215